Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Treasury Shares came in at $225000.0 in Q1 2026, down 77.27% YoY from $990000.0 in Q1 2025, and down 50.0% on a QoQ basis from $450000.0 in Q4 2025.
Black Diamond Therapeutics (BDTX) Treasury Shares (2018 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 9 years of Treasury Shares data on file, last reported at $225000.0 in Q1 2026.
- Quarterly Treasury Shares fell 77.27% year-over-year to $225000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225000.0 (down 77.27% YoY) and the FY2025 annual result came in at $450000.0, down 16.67% from the prior year.
- Treasury Shares declined to $225000.0 in Q1 2026, from $450000.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $990000.0 in Q1 2025 to a low of $19000.0 in Q4 2023.
- A 5-year average of $281181.4 and a median of $225000.0 in 2026 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2024 — Treasury Shares sank 91.5% — and 2025, when it soared 4964.2%.
- Tracing BDTX's Treasury Shares over 5 years: stood at $101397.0 in 2022, then slumped by 81.26% to $19000.0 in 2023, then soared by 2742.11% to $540000.0 in 2024, then fell by 16.67% to $450000.0 in 2025, then slumped by 50.0% to $225000.0 in 2026.
- The last three Treasury Shares figures came in at $225000.0 (Q1 2026), $450000.0 (Q4 2025), and $670000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Black Diamond Therapeutics | 125.92 Mn | 15.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 225,000.00 |
| Jun 30, 2026 | 225,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Mar 31, 2026 | 225,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Dec 31, 2025 | 450,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Sep 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 670,000.00 |
| Jun 30, 2025 | 670,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Dec 31, 2024 | 540,000.00 |
| Dec 31, 2024 | 540,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,549.00 |
| Mar 31, 2024 | 19,549.00 |